Portland, OR — 01/12/2018 — Blood Market Overview:

Global Blood Market was valued at $33,500 million in 2016, and is estimated to reach $45,982 million by 2023, growing at a CAGR of 4.6% from 2017 to 2023. Blood market involves the selling of whole blood & blood components through various channels, such as blood banks, hospitals, and others. The donor blood is collected and is segregated into required components for therapy purpose. A basic blood transfusion procedure involves the transfer of red blood cells from one person to another, usually at a hospital during a surgery. Whole blood is rarely utilized in transfusions anymore, and only the blood components are required by the recipient, owing to the advancement in the medical technology.

Increase in geriatric population, rise in incidence in trauma cases, technological advancement in medical technology for donor screening, and advancement in blood transfusion instruments are the major factors that drive the market growth. However, minimal invasive technology, which no longer need the blood transfusion, restrains the market growth. Improvement in the healthcare facilities in Asia-Pacific provide growth opportunities for the market.

Save Upto 15% on this Report @ https://www.researchbeam.com/blood-market/purchase-enquiry

Blood Market Market Segmentation

Segment Review

The global blood market is segmented based on product, end user, and geography. Based on product, it is classified into whole blood collection, source plasma collection, blood therapeutics, blood typing products, blood screening, and blood processing equipment & associated products. Blood therapeutics segment contributed the highest share in 2016, owing to the increase in the demand for various plasma proteins for the recovery of patients wellness. Further, based on whole blood collection, the market is bifurcated into systems and reagents. Source plasma collection is classified into system and reagents. Blood therapeutics are divided into intravenous immunoglobulin (IVIG), factor IX, factor VIII, hyperimmune, and albumins. Blood typing products are categorized into systems and reagents. Blood screening is divided into systems and reagents. Blood processing equipment & associated products are bifurcated into systems and reagents. Based on end user, the market is divided into blood & blood component bank, diagnostics laboratories, ambulatory surgical centers, hospitals, and others. Blood & blood component banks contributed highest share in 2016, owing to the increase in the demand for blood processing in the blood banks and for segregation of components in the blood.

Top Investment Pockets

Blood therapeutics is considered as the top investment pocket, owing to the significant growth opportunity. Blood therapeutics market is projected to grow at a highest CAGR of 5.0% during the analysis period, owing to the rise in demand for the use of blood components in treatments for fast recovery or healing purposes. Thus, the demand for blood components is high as compared to whole blood.

Top Investment Pockets for Global Blood Market

Geographical Analysis

Geographically, the market is divided into North America, Europe, Asia-Pacific, and LAMEA. North America held the leading position, owing to its well-developed healthcare industry and rise in number of patients population requiring blood & blood components. However, Asia-Pacific is anticipated to grow at a highest growth rate due to rise in government initiatives for the improvement of the healthcare facilities and increase in the number of blood banks.

Get the sample PDF Brochure of market study @ https://www.researchbeam.com/blood-market/request-sample

Key Benefits for Stakeholders

The study provides an in-depth analysis of the global blood market and current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis of the industry from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the market based on surgeries and products elucidates various trends and prevailing opportunities across segments.
Key market players operating are profiled to determine the competitive outlook of the market by studying the different products of the companies and their developments.
The key players profiled in the report include Abbott Laboratories, Baxter International Inc., Becton, Dickinson & Co., CSL Behring, Immucor, Novartis, Novo Nordisk, Ortho Clinical Diagnostics, Roche Diagnostics, and Grifols International SA.
List of the other players (not included in the report) Medimmune (AstraZeneca), Fresenius Kabi, Macopharma, Nipro Medical Corporation, Sarstedt AG & Co., and Thermo Fisher Scientific, Inc.

Blood Market Key Segments:

By Product

Whole Blood Collection
Whole Blood Collection Systems
Whole Blood Collection Reagents
Source Plasma Collections
Source Plasma Collection Systems
Source Plasma Collection Reagents
Blood Therapeutics
IVIG (Intravenous Immunoglobulin)
Factor IX
Factor VIII
Blood Typing Products
Blood Typing Systems
Blood Typing Reagents
Blood Screening
Blood Screening Systems
Blood Screening Reagents
Blood Processing Equipment & Associated Products
Blood Processing Equipment Systems
Blood Processing Equipment Reagents

By End User

Blood & Blood Component Bank
Diagnostic Laboratories
Ambulatory Surgical Centers
Others (Academic Institutes & Research Laboratories)

By Geography

North America
Rest of Europe
Rest of Asia-Pacific
Latin America
Middle East

Powered by WPeMatico